697739-12-1 Usage
General Description
Ethyl imidazo[1,5-a]pyridine-8-carboxylate is a chemical compound with a unique molecular structure. It belongs to the imidazo[1,5-a]pyridine family, which is known for its wide range of biological activities, including anti-inflammatory, antimicrobial, and anti-cancer properties. Ethyl iMidazo[1,5-a]pyridine-8-carboxylate is often used in medicinal chemistry research for the development of pharmaceutical drugs. It has shown promise in various studies for its potential therapeutic applications. Additionally, it possesses a diverse range of physical and chemical properties, making it a versatile compound for various industrial and research applications. Overall, ethyl imidazo[1,5-a]pyridine-8-carboxylate holds significant potential for future advancements in the fields of medicine and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 697739-12-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,7,7,3 and 9 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 697739-12:
(8*6)+(7*9)+(6*7)+(5*7)+(4*3)+(3*9)+(2*1)+(1*2)=231
231 % 10 = 1
So 697739-12-1 is a valid CAS Registry Number.
697739-12-1Relevant articles and documents
SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
-
, (2015/12/25)
Provided are substituted heteroaryl aldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods for their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation.
SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
-
, (2013/07/19)
Provided are substituted benzaldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods for their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation.
